Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.7K
Overview
84.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.3K
The pathophysiology of pneumonia involves the following steps:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latent Class Analysis Identifies Pulmonary Function Trajectory Phenotypes in Lung Transplant Recipients with Chronic Allograft Dysfunction.

medRxiv : the preprint server for health sciences·2026
Same author

Characteristics of interventional clinical trials registered in ClinicalTrials.gov, 2018-2023.

Journal of clinical and translational science·2026
Same author

The Natural History of Chronic Lung Allograft Dysfunction in Single and Bilateral Orthotopic Lung Transplant Recipients.

Transplantation·2026
Same author

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Expression of complement pathway genes is associated with progression of idiopathic pulmonary fibrosis.

Respiratory research·2026
Same author

Kinetics of local C3 production orchestrates neutrophil recruitment in lung injury.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Feb 22, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K

Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.

John Belperio1, Scott M Palmer2, S Sam Weigt1

  • 11 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Los Angeles, California; and.

Annals of the American Thoracic Society
|September 26, 2017
PubMed
Summary
This summary is machine-generated.

Infections like bacterial, viral, and fungal post-lung transplant can lead to chronic lung allograft dysfunction (CLAD). These infections trigger immune responses that damage the transplanted lung, increasing mortality.

Keywords:
bacteriachronic lung allograft dysfunctionfunguslung transplantvirus

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.5K
Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

25.4K

Related Experiment Videos

Last Updated: Feb 22, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.5K
Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

25.4K

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Infectious Diseases

Background:

  • Lung transplantation is a vital treatment for advanced lung disease.
  • Post-transplant complications, particularly infections, are major causes of mortality and graft dysfunction.
  • Chronic lung allograft dysfunction (CLAD) is a significant concern in lung transplant recipients.

Purpose of the Study:

  • To explore the role of infections in the development of chronic lung allograft dysfunction (CLAD) after lung transplantation.
  • To understand the mechanisms by which microbial infections contribute to CLAD.
  • To investigate the link between specific pathogens and CLAD development.

Main Methods:

  • Review of existing literature on infections in lung transplant recipients.
  • Analysis of the association between bacterial (Staphylococcus aureus, Pseudomonas aeruginosa), viral (cytomegalovirus, community-acquired respiratory viruses), and fungal (Aspergillus) infections and CLAD.
  • Examination of the proposed mechanistic pathways involving chemokine induction and immune cell infiltration.

Main Results:

  • Bacterial, viral, and fungal infections are associated with an increased risk of developing CLAD.
  • Microbial interactions with allograft cells stimulate chemokine production, recruiting recipient leukocytes.
  • This immune cell infiltration amplifies inflammation, potentially leading to alloresponse and graft dysfunction.

Conclusions:

  • Infections are key contributors to the pathobiology of CLAD and associated mortality.
  • Altered chemokine production resulting from microbe-allograft-host immune interactions plays a role in CLAD development.
  • Targeting infections may be crucial for improving long-term outcomes in lung transplant recipients.